Gatica Sebastian, Fuentes Brandon, Rivera-Asín Elizabeth, Ramírez-Céspedes Paula, Sepúlveda-Alfaro Javiera, Catalán Eduardo A, Bueno Susan M, Kalergis Alexis M, Simon Felipe, Riedel Claudia A, Melo-Gonzalez Felipe
Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile.
Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Front Microbiol. 2023 Jun 23;14:1198200. doi: 10.3389/fmicb.2023.1198200. eCollection 2023.
Sepsis is a life-threatening condition and a significant cause of preventable morbidity and mortality globally. Among the leading causative agents of sepsis are bacterial pathogens , , , , and , along with fungal pathogens of the species. Here, we focus on evidence from human studies but also include and cellular and molecular evidence, exploring how bacterial and fungal pathogens are associated with bloodstream infection and sepsis. This review presents a narrative update on pathogen epidemiology, virulence factors, host factors of susceptibility, mechanisms of immunomodulation, current therapies, antibiotic resistance, and opportunities for diagnosis, prognosis, and therapeutics, through the perspective of bloodstream infection and sepsis. A list of curated novel host and pathogen factors, diagnostic and prognostic markers, and potential therapeutical targets to tackle sepsis from the research laboratory is presented. Further, we discuss the complex nature of sepsis depending on the sepsis-inducing pathogen and host susceptibility, the more common strains associated with severe pathology and how these aspects may impact in the management of the clinical presentation of sepsis.
脓毒症是一种危及生命的病症,是全球可预防发病和死亡的重要原因。脓毒症的主要致病因素包括细菌病原体( 、 、 、 、 )以及 属真菌病原体。在此,我们专注于来自人体研究的证据,但也纳入了 以及 细胞和分子证据,探讨细菌和真菌病原体如何与血流感染及脓毒症相关联。本综述从血流感染和脓毒症的角度,对病原体流行病学、毒力因子、宿主易感性因素、免疫调节机制、当前治疗方法、抗生素耐药性以及诊断、预后和治疗的机会进行了叙述性更新。列出了研究实验室中精心挑选的新型宿主和病原体因素、诊断和预后标志物以及应对脓毒症的潜在治疗靶点。此外,我们讨论了取决于引发脓毒症的病原体和宿主易感性的脓毒症的复杂性质、与严重病理相关的更常见菌株,以及这些方面如何可能影响脓毒症临床表现的管理。